当前位置:首页 - 行情中心 - 南新制药(688189) - 财务分析

南新制药

(688189)

  

流通市值:19.43亿  总市值:19.43亿
流通股本:2.74亿   总股本:2.74亿

南新制药(688189)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.05亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益129900.63万元,未分配利润-14803.34万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产169529.78万元,负债39629.15万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入111,835,236.68744,601,965.89562,058,852.86513,749,677.21
营业总成本89,089,221.39628,167,166.97508,120,982.75434,419,987.44
营业利润4,554,127.437,412,231.1-4,929,907.4526,830,201.19
利润总额5,083,987.37,607,254.86-1,900,148.5128,632,808.89
净利润4,677,245.815,954,771.39998,459.6232,687,596.59
其他综合收益----
综合收益总额4,677,245.815,954,771.39998,459.6232,687,596.59
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计1,245,613,160.931,290,011,027.371,231,656,921.131,416,428,938.78
非流动资产合计449,684,633.07447,525,439.08445,571,216.65451,546,455.96
资产总计1,695,297,7941,737,536,466.451,677,228,137.781,867,975,394.74
流动负债合计390,669,614.03429,441,961.38371,987,822.3530,644,295.41
非流动负债合计5,621,878.785,768,065.327,870,187.58,271,834.39
负债合计396,291,492.81435,210,026.7379,858,009.8538,916,129.8
归属于母公司股东权益合计1,313,885,150.781,318,116,026.61,315,015,056.41,342,772,735.41
股东权益合计1,299,006,301.191,302,326,439.751,297,370,127.981,329,059,264.94
负债和股东权益合计1,695,297,7941,737,536,466.451,677,228,137.781,867,975,394.74
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计129,273,393.29867,926,681.83626,379,760.43521,124,633.64
经营活动现金流出小计92,409,836.22652,696,154.54537,795,249.95468,682,320.11
经营活动产生的现金流量净额36,863,557.07215,230,527.2988,584,510.4852,442,313.53
投资活动现金流入小计-61,100--
投资活动现金流出小计10,882,764.95131,949,568.78,277,653.849,281,377.09
投资活动产生的现金流量净额-10,882,764.95-131,888,468.7-8,277,653.84-9,281,377.09
筹资活动现金流入小计3,572,609.97438,800,000150,000,000115,000,000
筹资活动现金流出小计47,973,027.73673,884,639.76441,887,142.58249,837,173.57
筹资活动产生的现金流量净额-44,400,417.76-235,084,639.76-291,887,142.58-134,837,173.57
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-18,419,625.64-151,742,581.17-211,580,285.94-91,676,237.13
期末现金及现金等价物余额543,309,757.82561,729,383.46501,891,678.69621,795,727.5
TOP↑